Mahmoud Saleh to Antineoplastic Agents
This is a "connection" page, showing publications Mahmoud Saleh has written about Antineoplastic Agents.
Connection Strength
0.501
-
El-Bayaa MN, Srour AM, Alanzy AL, Messaoudi S, Abd-Rabou AA, Saleh A, Saleh MGA, El-Sayed WA. Synthesis, anticancer activity and computational studies of new benzimidazole-triazole-pyridine glycoside conjugates. Future Med Chem. 2025 Dec; 17(24):2927-2943.
Score: 0.129
-
Kassem AF, Mounier MM, Abdelglil MI, Abdelwahed S, El-Rashedy AA, Saleh A, Saleh MGA, Srour AM. Dual Anticancer and COX-2 Inhibitory Activity of Tailored Paracetamol-Alkanesulfonate Conjugates: A Promising Therapeutic Approach. Arch Pharm (Weinheim). 2025 Oct; 358(10):e70125.
Score: 0.128
-
Srour AM, El-Bayaa MN, Temirak A, Alanzy AL, Awad HM, Saleh A, Saleh MG, El-Sayed WA. New benzimidazole-triazole glycoconjugates as anti-cancer agents and EGFR inhibitors. Sci Rep. 2025 Jul 15; 15(1):25514.
Score: 0.126
-
El-Bayaa MN, Kotb ER, Messaoudi S, Awad HM, Saleh MG, Soliman HA. Synthesis, anticancer activity, docking and computational studies of new pyridyl-glycosyl hybrids and acyclic analogs. Future Med Chem. 2024; 16(20):2119-2133.
Score: 0.119